Approach to managing hypoglycemia in elderly patients with diabetes

Postgraduate Medicine

Volumn 122, Issue 3, 2010, Pages 129-137

  Alagiakrishnan, Kannayiram ^a   Mereu, Laurie ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Diabetes; Elderly; Hypoglycemia; Hypoglycemic unawareness; Insulin; Oral antidiabetic agents

Indexed keywords

ATENOLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCAGON; GLUCOSE; INSULIN; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; MEGLITINIDE; NATEGLINIDE; PIG INSULIN; REPAGLINIDE; SULFONYLUREA DERIVATIVE; ANTIDIABETIC AGENT;

AGING; ARTICLE; ASYMPTOMATIC DISEASE; BLOOD GLUCOSE MONITORING; CLINICAL FEATURE; COGNITIVE DEFECT; DIABETES MELLITUS; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG HALF LIFE; ELDERLY CARE; FASTING HYPOGLYCEMIA; GLYCEMIC CONTROL; HEALTH CARE PERSONNEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MORBIDITY; NOCTURNAL HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PATIENT EDUCATION; POLYPHARMACY; PRIMARY PREVENTION; RANDOM HYPOGLYCEMIA; RISK FACTOR; THERAPY DELAY; AGE; AGED; BLOOD; PATHOPHYSIOLOGY;

AGE FACTORS; AGED; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; PATIENT EDUCATION AS TOPIC;

EID: 77953091582     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2010.05.2150     Document Type: Article

References (60)

1. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes. Diabetes Care. 2005;28(12):2948-2961.
2. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1992-2002. Diabetes Care. 2006;29:1263-1268.
3. Boyle JP, Honeycutt AA, Narayan V, et al. Projection of diabetes burden through 2050 impact of changing demography and disease prevalence in the United States. Diabetes Care. 2001;24(11):1936-1940.
4. Bertoni AG, Krop JS, Anderson GF, Brancati FL. Diabetes-related morbidity and mortality in a national sample of U.S. elders. Diabetes Care. 2002;25(3):471-475.
5. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26(6):1902-1912.
6. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group. Am J Med. 1991;90(4):450-459.
7. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-853.
8. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complication Trial. The Diabetes Control and Complications Trial Research Group. Diabetes. 1997;46(2):271-286.
9. Davis S, Alonso MD. Hypoglycemia as a barrier to glycemic control. J Diabetes Complications. 2004;18(1):60-68.
10. Cholstein A, Plaschke A, Egherts EH. Incidence and costs of severe hypoglycemia. Diabetes Care. 2002;25(11):2109-2110.
11. American Diabetes Association. Diabetes management in correctional institutions. Diabetes Care. 2010;33(suppl 1):S75-S81.
12. Canadian Diabetes Association. Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes. 2008;32(1):S48-S64, S150-S157.
13. Yale JF, Begg I, Gerstein H, et al. 2001 Canadian Diabetes Association clinical practice guidelines for the prevention and management of hypoglycemia in diabetes. Canadian Journal of Diabetes. 2002;26(1):22-35.
14. Jaap AJ, Jones GC, McCrimmon RJ, et al. Perceived symptoms of hypoglycemia in elderly type 2 diabetic patients treated with insulin. Diabet Med. 1998;15(5):398-401.
15. Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V. Association of hypoglycemia and cardiac ischemia. Diabetes Care. 2003;26(5):1485-1489.
16. Phillips P, Popplewell P. Diabetes and dementia. Medicine Today. 2002;3(11):30-40.
17. Langan SJ, Deary IJ, Hepburn DA, Frier BM. Cumulative cognitive impairment following recurrent severe hypoglycemia in man. Diabetologia. 1991;34(5):337-344.
18. Whitner RA, Karter JA, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301(15):1565-1572.
19. Chelliah A, Burge MR. Hypoglycemia in elderly patients with diabetes mellitus: cause and strategies for prevention. Drugs Aging. 2004;21(8):511-530.
20. Donnelly LA, Morris AD, Frier BM, et al; DARTS/MEMO Collaboration. Frequency and predictors of hypoglycemia in Type 1 and insulin-treated Type 2 diabetes: A population based study. Diabet Med. 2003;22(6):449-455.
21. Matyka K, Evans M, Lomas J, Cranston I, Macdonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care. 1997;20(2):135-141.
22. Brierley EJ, Broughton DL, James OF, Alberti KG. Reduced awareness of hypoglycemia in the elderly despite an intact counter-regulatory response. QJ Med. 1995;88(6):439-445.
23. Meneilly GS, Cheung E, Tuokko H. Altered responses to hypoglycemia of healthy elderly people. J Clin Endocrin Met. 1994;78(6):1341-1348.
24. Meneilly GS, Cheung E, Tuokko H. Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes. 1994;43(3):403-410.
25. Mitrakou A, Ryan C, Veneman T, et al. Hierarchy of glycemic thresholds for counter regulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol. 1991;260:E67-E74.
26. Matyka K, Evans M, Lomas J, Cranston I, Macdonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care. 1997;20(2):135-141.
27. Brener JP, Jauch-Chara K, Hallschmid M, Schmid S, Schultes B. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care. 2009;32:1513-1517.
28. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977-986.
29. Brener JP, Jauch-Chara K, Hallschmid M, et al. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care. 2009;32:1513-1517.
30. Stephenson JM, Kempler P, Perin PC, Fuller JH. Is autonomic neuropathy a risk factor for severe hypoglycemia? The EURODIAB IDDM Complications Study. Diabetologia. 1996;39(11):1372-1376.
31. Segel SA, Paramore DS, Cryer PE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes. 2002;51(3):724-733.
32. Cryer PE. Mechanisms of hypoglycemia associated autonomic failure and its component syndromes in diabetes. Diabetes. 2005;54(12):3592-3598.
33. Hofeldt FD. Reactive hypoglycemia. Endocrinol Metab Clin North Am. 1989;18:185-201.
34. Brun JF, Fedou C, Mercier J. Postprandial reactive hypoglycemia. Diabetes Metab. 2000;26(5):337-351.
35. Bolli GB, Periello G, Fanelli CG, DeFeo P. Nocturnal blood glucose control in type 1 diabetes mellitus. Diabetes Care. 1993;16(suppl 3):71-89.
36. Gill CV, Alberta KG. Diabetic hypoglycemia. Pract Diabetes. 1985;2:5-10.
37. Pramming S, Thorsteinsson B, Bendston I, Rønn B, Binder C. Nocturnal hypoglycemia in patients receiving conventional treatment of insulin. BMJ. 1985;291(6492):376-379.
38. De Feo P, Perriello G, Bolli GB. Somogyi and Dawn phenomena: mechanisms. Diabetes Metab Rev. 1988;4(1):31-49.
39. Jones TW, Porter P, Sherwin RS, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med. 1998;338(23):1657-1662.
40. Alagiakrishnan K, Lechelt K, McCracken P, Torrible S, Sclater A. Atypical presentation of silent nocturnal hypoglycemia in an older person. J Am Geriatr Soc. 2001;49(11):1577-1578.
41. Fajans SS, Floyd JC. Fasting hypoglycemia in adults. N Engl J Med. 1976;294(14):766-772.
42. Zimmerman BR. Sulphonylureas. Endocrinol Metab Clin North Am. 1997;26(3):511-522.
43. Seltzer HS. Drug-induced hypoglycemia. A review of 1418 cases. Endocrinol Metab Clin North Am. 1989;18(1):163-183.
44. Berger W, Caduff F, Pasquel M, Rump A. The relatively frequent incidence of severe sulfonylurea-induced hypoglycemia in the last 25 years in Switzerland. Results of two surveys in Switzerland in 1969 and 1984 [in German]. Schweiz Med Wochenschr. 1986;116(5):145-151.
45. Walter MW. Hypoglycemia: still a risk in the elderly. Geriatrics. 1990;45:69-75.
46. Brunelle BL, Llewelyn J, Anderson JH Jr, Gale EA, Koivisto VA. Metaanalysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care. 1998;21(10):1726-1731.
47. Porcellati F, Rossetti P, Fanelli C, Lcionti L, Brunetti P, Bolli GB. Glargine vs NPH as basal insulin in intensive treatment of type 1 diabetes mellitus given lispro at meals: one year comparison. Diabetes. 2002;51(suppl 2):A217.
48. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):713-720.
49. Herings RM, Deboer A, Stricker BH, et al. Hypoglycemia associated with use of inhibitors of angiotensin converting enzyme. Lancet. 1995;345(8959):1195-1198.
50. Hepburn DA, Macleod KM, Fell AC, Scougal IJ, Frier BM. Frequency and symptoms of hypoglycemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med. 1993;10(3):231-237.
51. Donnelly LA, Morris AD, Frier BM, et al; DARTS/MEMO Collaboration. The DARTS/MEMO collaboration: Frequency and predictors of hypoglycemia in type 1 and insulin treated type 2 diabetes: a population based study. Diabet Med. 2003;22(6):449-455.
52. Gabriely I, Shamoon H. Hypoglycemia in diabetes: common, often unrecognized. Cleveland Clin J Med. 2004;71(4):335-342.
53. Briscoe VJ, Davis SN. Hypoglycemia in type 1 and type 2 diabetes: physiology, pathophysiology, and management. Clinical Diabetes. 2006;24(3):115-121.
54. Doucet J. Use of antidiabetic drugs in elderly patients. Diabetes Metab. 2005;31(2):5S98-5S104.
55. Heller SR, Amiel SA, Mansell P. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. Diabetes Care. 1999;22(10):1607-1611.
56. Cryer PE, Childs BP. Negotiating the barrier of hypoglycemia in diabetes. Diabetes Spectrum. 2002;15:20-27.
57. Raju B, Arbelaez AM, Breckenridge SM, Cryer PE. Nocturnal hypoglycemia in type 1 diabetes: An assessment of bedtime treatments. J Clin Endocrinol Metab. 2006;91(6):2087-2092.
58. Fanelli C, Pampanelli S, Epifano L. Long-term recovery from unawareness, deficient counter regulation, and lack of cognitive dysfunction during hypoglycemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia. 1994;37(12):1265-1276.
59. Brown AF, Mangione CM, Saliba D, Sarkisian CA; California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older persons with diabetes mellitus. J Am Geriatr Soc. 2003;51(5 suppl guidelines):S265-S280.
60. Cayea D, Boyd C, Durso SC. Individualising therapy for older adults with diabetes mellitus. Drugs Aging. 2007;24(10):851-863.